Coordinated at the Josep Carreras Leukaemia Research Institute by Marcus Buschbeck, INTERCEPT-MDS brings together 10 European public and private expert host institutions to create a European network of experts in leukaemia, epigenetics and single cell genomics.
In addition, we count with the support of 9 partner organizations that will provide state-of-the-art complementary training and a novel educational program in an environment of excellence, innovation and multidisciplinarity.
Josep Carreras Leukaemia Research Institute
Created in 2010, the Josep Carreras Institute mission is to investigate the epidemiological, preventive, clinical, translation and basic aspects of leukaemia and other hematologic malignancies through innovation to cure them.
Erasmus University Medical Center (Erasmus MC)
Erasmus MC is one of the largest scientific University Medical Centres in Europe and is recognized as a world-class scientific research organization aiming to improve our understanding of diseases and disorders and helps to predict, treat and prevent them.
Klinikum rechts der Isar der TU München
Founded in 1834, Klinikum rechts der Isar is the university hospital of the Technical University Munich. It stands for state-of-the-art medicine, research and advancement.
Institut national de la sante et de la recherche medicale (Inserm)
Inserm is a public research organization entirely dedicated to human health. Its objective is to promote the health of all by advancing knowledge about life and disease, treatment innovation, and public health research.
Veterinärmedizinische Universität Wien (Vetmeduni)
In addition to applied and clinical research, the University of Veterinary Medicine in Vienna conducts excellent basic research in veterinary medicine.
Università degli Studi di Firenze (UNIFI)
The Department of Experimental and Clinical Medicine (DMSC) is situated within one of the largest hospitals of Italy and favours the study of clinical cases within internationally-recognized centres of excellence, driving a high-quality level of clinical and experimental research.
Institute for Tumor Biology and Experimental Therapy, Georg-Speyer-Haus (GSH)
Established in 1904, GSH is a public scientific institute performing internationally competitive basic research in the field of tumour biology with a particular focus on the tumour microenvironment. Through close collaboration with clinical partners it is also considered a centre of translational oncology.
MLL Munich Leukemia Laboratory
MLL is a leading institution from the private sector for leukaemia diagnostics and research, operating within a highly innovative environment.
University of Bergen (UiB)
UiB is an internationally-recognized research university with a high international profile and several centres of excellence.
BioBam is a leading bioinformatics solution provider which accelerate research in disciplines such as agricultural genomics, microbiology and environmental NGS studies, amongst others.
GenomeScan is a leading service company in molecular genetics. Based in Leiden (The Netherlands), its main activities are next-generation sequencing (NGS), gene expression analysis, SNP genotyping and methylation analysis.
European Hematology Association (EHA)
EHA is the largest European-based organization connecting hematologists worldwide to support career development and research, harmonize hematology education, and advocate for hematologists and hematology.
Located in Baden-Baden (Germany), Leadership Sculptor focuses on supporting the development of leadership and project management skills in R&D, especially in the life sciences.
Connaître et Combattre les Myélodysplasies (CCM)
Since July 2006, CCM has been supporting people suffering from Myelodysplastic Syndrome and their relatives with the scientific partnership of the Groupe Francophone des Myelodysplasies (GFM).
Universitat Autònoma de Barcelona (UAB)
The UAB is one of the major public universities in Spain. It is recognised for its efforts in promoting quality in teaching, in attracting international talent and in obtaining a growing impact in research.
Aelian Biotechnology is an SME based in Vienna. It combines CRISPR screening with single-cell sequencing, leveraging two transformative technologies to enable genetic screening for complex phenotypes.
CSIC – Institute for Integrative Systems Biology (I2SysBio)
The I2SysBio is a joint research institute involving Universitat de València (UV) and Agencia Estatal del Consejo Superior de Investigaciones Científicas (CSIC), open to strategic alliances with biotech companies.
Université de Paris (UPa)
UPa is a public university in France, fully multidisciplinary in terms of both training and research. Its strategic portfolio of academic partners around the world enables it to offer its students cutting-edge and innovative training courses.
Universitätsklinikum Aachen AöR (UKA)
The University Clinic RWTH Aachen offers first-class medicine. Bundling patient care, research and teaching under one roof – a concept which is unique both architecturally and in terms of organisation – facilitates intensive interdisciplinary dialogue and a dense clinical and scientific network.
University of Florida (UF)
UF is a public research university in Gainesville, (Florida, USA). It is one of sixty-two elected member institutions of the Association of American Universities (AAU), the association of pre-eminent North American research universities, and the only AAU member university in Florida.
Scienseed is a growing company specializing in scientific communication. With a focus on bridging the gap between complex research and broader audiences, Scienseed offers expertise in conveying scientific concepts in clear, engaging, and accessible ways. Through various communication channels, Scienseed aims to facilitate the dissemination of scientific knowledge and promote a better understanding of research findings among diverse audiences.